Detalles de la búsqueda
1.
A phase 3 trial of bevacizumab in ovarian cancer.
N Engl J Med
; 365(26): 2484-96, 2011 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22204725
2.
Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the ago-study group (AGO GYN 5).
Gynecol Oncol
; 133(3): 427-32, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24713545
3.
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5).
Int J Gynecol Cancer
; 24(2): 260-5, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24418927
4.
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV.
Gynecol Oncol
; 126(2): 236-40, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22564713
5.
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).
Gynecol Oncol
; 105(1): 132-7, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17161453
6.
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.
J Clin Oncol
; 24(29): 4699-707, 2006 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16966687
7.
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
J Natl Cancer Inst
; 98(15): 1036-45, 2006 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-16882940
Resultados
1 -
7
de 7
1
Próxima >
>>